The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
p53 pathway genes' mutations as prognostic factors in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): A single center study.
 
Giovanni Trovato
No Relationships to Disclose
 
Diletta Barone
No Relationships to Disclose
 
Alexia Spring
No Relationships to Disclose
 
Angelo Minucci
No Relationships to Disclose
 
Laura Chiofalo
No Relationships to Disclose
 
Serena Perazzo
No Relationships to Disclose
 
Anna Ceccarelli
No Relationships to Disclose
 
Linda Di Francesco
No Relationships to Disclose
 
Antonia Cosmai
No Relationships to Disclose
 
Gloria Messina
No Relationships to Disclose
 
Alessia Preziosi
No Relationships to Disclose
 
Luciano Giaco'
No Relationships to Disclose
 
Maria Bensi
No Relationships to Disclose
 
Cinzia Bagalà
No Relationships to Disclose
 
Giampaolo Tortora
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Celgene; Dompé Farmaceutici; Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; Roche
 
Lisa Salvatore
Honoraria - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Incyte; Merck Serono; MSD; Pierre Fabre; SERVIER; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Incyte; Merck Serono; MSD; Pierre Fabre; SERVIER; Takeda
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Pierre Fabre; SERVIER